$599

Zverev Sports MiniMed at Wimbledon; CSPC/AZ Milestone Payment; Madrigal Rezdiffra Patents; Novo AMAZE 3 Zenagamtide Study

A series of cardiometabolic-related news items has been observed from MiniMed, CSPC Pharmaceutical, Madrigal Pharmaceuticals, and Novo Nordisk. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here